5 min read THERE’S BEEN A lot of talk of “revolutionary” drugs lately, thanks to GLP-1s like Ozempic that changed how obesity is treated. Now scientists are trying to replicate a similar groundbreaking feat in the world of sleep. Introducing AD109: a once-daily sleep apnea pill intended to eventually replace clunky CPAP machines. The experimental drug has generated a lot of buzz. Scientists have been calling it the “ holy grail " treatment for sleep apnea, a sleep apnea “ star ,” among other things. It’s not completely unsubstantiated. The parent company, Apnimed, recently released Phase 3 clinical trial results showing some promising results across people from mild to severe sleep apnea. While not available yet in stores, the FDA has fast-tracked the application with a decision expected in early 2027. Scientists involved with drug development are hopeful this nightly pill will eliminate most symptoms of sleep apnea, including loud snoring. But when you ask sleep doctors, their reactions are…not as stoked.…